Menu
16th Annual Conference PSSLD, 2-4 December 2022
Menu
| Time | Topic | Speaker |
|---|---|---|
|
09:00 - 9:15 |
EUS-guided diagnostic hepatic procedures: Targeted and non-targeted biopsy, elastography & portal pressure measurements |
Amjad Salamat |
|
09:16 - 9:30 |
EUS guided Hemostasis |
Mostafa Ibrahim |
|
09:31 - 9:45 |
Endoscopic management of biliary complications |
Mostafa Arain |
|
09:46 - 10:00 |
EUS guided biliary decompression: A local experience |
Ghias Un Nabi Tayyab |
|
10:01 - 10:15 |
Q & A | Quiz |
|
|
10:16 - 10:30 |
Tea Break |
|
| Time | Topic | Speaker |
|---|---|---|
|
10:31 - 10:45 |
Management of uncomplicated chronic hepatitis B |
Faisal Wasim |
|
10:46 - 11:00 |
A simplified algorithm for the management of uncomplicated hepatitis C |
Masood Siddiq |
|
11:01 - 11:15 |
Be a micro-eliminator: Physician’s contribution to preventing hepatitis B, C, and D in everyday practice |
Faridah Amin |
|
11:16 - 11:30 |
NAFLD: How to screen at-risk populations during routine practice? |
Aisha Sheikh, Farina Hanif |
|
11:31 - 11:45 |
Should we screen every NAFLD patient for cardiovascular disease? |
Muslim Atiq |
|
11:46 - 12:00 |
Q & A | Quiz |
|
| Time | Topic | Speaker |
|---|---|---|
|
12:01 - 12:15 |
Pakistan’s progress in the elimination of hepatitis C |
Huma Qureshi |
|
12:16 - 12:30 |
Simplified and decentralized HCV care: Could it be a new norm for Pakistan? |
Zaigham Abbas |
|
12:31 - 12:50 |
Are there any Noval models to amplify the elimination of hepatitis C in Pakistan? |
Homie Razavi |
|
12:50 - 13:00 |
Q & A |
|
|
13:00 - 14:00 |
Lunch & Prayers |
|
| Time | Topic | Speaker |
|---|---|---|
|
14:00 - 14:15 |
Operating on a patient with cirrhosis: Risk stratification and optimization of pre and post-operative care? |
Yasir Zaidi |
|
14:16 - 14:30 |
A 45-year-old male with recurrent abdominal pain, jaundice, and biliary strictures |
Muhammad Kamran |
|
14:31 - 14:45 |
A 25-year-old female with 32 weeks of gestational amenorrhea and acutely deranged LFTs |
Sadiq Memon |
|
14:46 - 15:00 |
A 68-year-old man with ascites and persistent hyponatremia |
Mohamed Alboraie |
|
15:01 - 15:30 |
A 50-year-old male with pain in the right hypochondrium and cysts in the liver and lung |
Necati Örmeci |
|
15:31 - 16:00 |
Q & A | Quiz |
|
|
16:01 - 16:15 |
Tea Break |
|
| Time | Topic | Speaker |
|---|---|---|
|
16:16 - 16:30 |
Hepatitis B elimination: Are we on track with the WHOs Global hepatitis strategy? |
Saeed Hamid |
|
16:31 - 16:45 |
“Hepatitis B United”: Is this a viable approach for Pakistan? |
Robert Gish |
|
16:46 - 17:00 |
Expanding vaccine coverage: Learning from success stories and way forward for Pakistan |
Homie Razavi |
|
17:01 - 17:15 |
Mother to Child transmission: Strategies for Pakistan to mitigate the risk |
Amna Subhan Butt |
|
17:16 - 17:30 |
Impact of hepatitis B vaccination programs on HBV and HCC prevalence |
Bilal Hameed |
|
17:31 - 17:45 |
HBV and at-risk population: Screening & harm reduction services |
Asad Chaudhary |
|
17:46 - 18:10 |
Q & A |
|
|
|
||
|
17:00 - 19:00 |
E-Poster Presentations Chairs: Badar F. Zubairi, Husnain Ali Shah, Junaid Saleem |
|
| Time | Topic |
|---|---|
|
19:00 - 19:05 |
Recitation from the Holy Quran |
|
19:06 - 19:10 |
National Anthem (Video) |
|
|
Addresses |
|
19:11 - 19:15 |
Patron PSSLD |
|
19:16 - 19:20 |
President PSSLD |
|
19:21 - 19:25 |
Chair Organizing Committing |
|
19:26 - 19:30 |
Chair Scientific Committee |
|
19:31 - 19:50 |
Theme Lecture: Emerging Trends in Hepatology: Challenges and Opportunities Wasim Jafri |
|
19:51 - 20:05 |
Chief Guest |
|
20:06 - 20:15 |
Awards |
|
20:16 - 20:20 |
Vote of thanks: Vice President-PSSLD |
|
20:21 - 21:00 |
Dinner |
| Time | Topic | Speaker |
|---|---|---|
|
07:30 - 9:00 |
The use of machine learning to forecast radio-anomalies in liver |
Saman Shahid |
|
Long-term sustained virological response with generic DAAS: An important but often missed perspective of management of HCV |
Umair Shafqat |
|
|
Comparison of diagnostic accuracy of plasma lactate and ascitic fluid lactate in predicting one-month mortality in spontaneous bacterial peritonitis |
Danish Kumar |
|
|
Correlation Between Number Of Dialysis Sessions done in Patients With CKD & the frequency of HCV Infection in patients with CKD On Hemodialysis |
Muhammad Yasir Younis |
|
|
Biliary atresia-an experience from the first pediatric liver transplant center in Pakistan |
Sabeen Abid Khan |
|
|
Bedside nutritional assessment in cirrhotic patients: A cross-sectional study |
Asif Khan |
|
|
Does spleen steatosis measured by transient elastography correlate with liver steatosis? |
Abeer Altaf |
|
|
Comparison of vitamin D levels in normal population and patients with chronic liver diseases conferring to child-pugh classification in northern Sindh, Pakistan |
Salma Lakho |
|
|
Comparative Analysis of Intravenous Ceftriaxone and Ciprofloxacin for the Treatment of Bacterial Peritonitis in Liver Cirrhosis |
Arbab Muhammad Kashif |
|
|
A cluster randomized controlled study of secondary distribution of HCV self-test to support micro-elimination in Karachi, Pakistan |
Aliya Husnain |
|
|
07:30 - 09:00 |
E-Poster Presentations Chairs: Nasir Luck, Muhammad Kamran, Farina Hanif |
|
| Time | Topic | Speaker |
|---|---|---|
|
9:01 - 9:20 |
Managing HBV: Utility of quantitative HBsAg and novel biomarkers |
Robert Gish |
|
9:21 - 9:40 |
Functional Cure of Hepatitis B: New virological and immunological targets |
Norah Terrault |
|
9:41 - 10:00 |
HBV: Treat or not to treat dilemmas |
Altaf Alam |
|
10:01 - 10:20 |
HBV Therapy: Stop or not to stop dilemmas |
Norah Terrault |
|
10:21 - 10:40 |
HDV therapy beyond Pegylated Interferon: Hopes and limitations? |
Cihan Yurdaydin |
|
10:41 - 11:00 |
Q & A | Quiz |
|
|
11:01 - 11:15 |
Tea Break |
|
| Time | Topic | Speaker | |
|---|---|---|---|
|
11:16 - 11:35 |
Managing HCV in children and pregnant women |
Nancy S. Reau |
|
|
11:36 - 11:55 |
Treatment failure after first-line therapy: How to proceed? |
Ammara Naveed |
|
|
11:56 - 12:15 |
Difficult to treat patients (Patients with renal failure, malignancies, on immunosuppressive medications, post-transplant, HCV-HIV co-infection) |
Bilal Hameed |
|
|
12:16 - 12:35 |
Long-term follow-up after HCV eradication therapy: Who to follow & how to follow? |
K. Rajender Reddy |
|
|
12:36 - 13:00 |
Q & A | Quiz |
||
|
13:01 - 14:00 |
Lunch & Prayers |
||
|
13:01 - 14:00 |
PSSLD Steering Committee Meeting |
Venue: |
|
| Time | Topic | Speaker |
|---|---|---|
|
14:01 - 14:15 |
Portal vein thrombosis: Restoring flow and managing anticoagulation |
Anil Arora |
|
14:16 - 14:30 |
Variceal Bleed: Advancement in endoscopic management and prophylactic measures |
Ibrahim Mostafa |
|
14:31 - 14:45 |
Post bleeding & Peri-procedural anticoagulation in cirrhosis: When to stop & restart? |
Rajender Reddy |
|
14:46 - 15:00 |
An update on the management of Budd Chiari Syndrome |
Nasir Luck |
|
15:01 - 15:20 |
Q & A | Quiz |
|
|
15:21 - 15:30 |
Tea Break |
|
|
15:01 - 16:00 |
PSSLD Executive Committee Meeting |
|
| Time | Topic | Speaker |
|---|---|---|
|
15:31 - 15:45 |
Stages of cirrhosis and how to prevent decompensation |
Necati Örmeci |
|
15:46 - 16:00 |
Insights about good and bad albumin in end-stage liver disease |
Nadeem Tehami |
|
16:01 - 16:15 |
Infections in end-stage liver disease |
Qin Ning |
|
16:16 - 16:30 |
Management of HRS-AKI and refractory ascites in light of the new classification |
Syed Anjum Gardezi |
|
16:31 - 16:45 |
What is new in the management of Portosystemic Encephalopathy? |
Ashfaq Ahmed |
|
16:46 - 17:00 |
Q & A |
|
| Time | Topic | Speaker |
|---|---|---|
|
17:01 - 17:20 |
Emerging trends in the management of Acute on Chronic Liver Failure |
Yogesh Chawla |
|
17:21 - 17:30 |
Q & A |
|
| Time | Topic |
|---|---|
|
17:31 - 18:30 |
Quiz competition |
| Time | Topic | Speaker |
|---|---|---|
|
07:30 - 09:00 |
Comparison of N-Terminal Pro Brain Natriuretic Peptide in Patients with Child-Pugh Class A, B and C |
Muhammad Adnan Shahzad |
|
Validation and Exploratory Factor Analysis of Urdu Version of Chronic Liver Disease Questionnaire |
Sana Muhammad Hussain |
|
|
Level of Awareness and Knowledge of Hepatitis B Post-Exposure Prophylaxis Among Health Care Providers in Quetta |
Mahrukh Ali |
|
|
Donor's Quality of Life After Living Donor Liver Transplantation in A Single-Center Experience |
Anas Ahmad Shah |
|
|
Characterization of Hepatitis B and Delta Co-Infection Viral Kinetics in Pakistan |
Sahar Sultana |
|
|
Long-Term Bone Safety Of Tenofovir Disoproxil Fumarate In Chronic Hepatitis B Patients |
Hanisha Khemani |
|
|
Platelet Count to Spleen Diameter Ratio; A non-invasive predictor of High-Risk Esophageal Varices |
Muhammad Ahmed |
|
|
Anti–diabetic drug combination employed in the prevention of non-alcoholic steatohepatitis |
Asma Abdul Razzak |
|
|
Zinc Supplementation in Management of Hepatic Encephalopathy in Patients with Cirrhosis; A Study Conducted in Developing Country |
Fareeda Irshad |
|
|
Weekends vs weekdays admission with upper gastrointestinal bleed: Is there any difference in outcome? |
Syedda Ayesha |
| Time | Topic | Speaker |
|---|---|---|
|
9:01 - 9:15 |
NAFLD: Pathogenesis & therapeutic targets |
Arun Sanyal |
|
9:16 - 9:30 |
Anti-diabetic medications: Is there any role in treating NAFLD |
Zobair Younossi |
|
9:31 - 9:45 |
NAFLD-overlap syndrome (NAFLD with HBV/HCV/AIH): What should be the approach |
Ajay Kumar Duseja |
|
9:45 - 10:00 |
Q & A |
|
| Time | Topic | Speaker |
|---|---|---|
|
10:01 - 10:15 |
Minimal invasive surgery in LDLT |
Dieter Broering / Wahab Dogar |
|
10:16 - 10:30 |
Enhanced recovery after surgery (ERAS) in the setting of LDLT |
Syed Shareef |
|
10:31 - 10:45 |
Post-LDLT immunosuppressive therapy: the preferred regimen |
Khalid Mumtaz |
|
10:46 - 11:00 |
A 50-year-old underwent LDLT developed deranged LFT on the 14th postoperative day (D/D T cell-mediated rejection) |
Osama Tariq But |
|
11:01 - 11:15 |
Q & A | Quiz |
|
|
11:16 - 11:30 |
Tea Break |
|
| Time | Topic | Speaker |
|---|---|---|
|
11:31 - 11:45 |
Down-staging HCC before curative treatment |
Muhammad Salih |
|
11:46 - 12:00 |
The new algorithm for systemic and immunotherapy |
Adnan Jabbar |
|
12:01 - 12:20 |
Current perspective in LDLT for HCC |
Mohamed Rela |
|
12:21 - 13:00 |
Q & A | Quiz |
|
| Time | Topic | Speaker |
|---|---|---|
|
12:31 - 12:45 |
Autoimmune hepatitis with and without cirrhosis: Current and future treatment |
Muhammad Akram |
|
12:46 - 13:00 |
PBC and PSC: Updates in diagnosis and management |
Farhana Kayani |
|
13:01 - 13:15 |
Complementary and alternate medications and DILI |
Shahab Abid |
|
13:16 - 13:30 |
Emerging concepts in the management of alcohol-associated liver disease |
Nazish Butt |
|
13:31 - 13:45 |
Sarcopenia and nutritional issues in liver disease |
Rustam Khan |
|
13:46 - 14:00 |
End-of-life care in cirrhotic patients |
Shahid Rasool |
|
14:01 - 14:15 |
Pain management in chronic liver disease |
Mudassir Laeeq |
|
14:15 - 14:30 |
Q & A | Quiz |
|
| Time | Topic |
|---|---|
|
14:31 - 14:45 |
Awards distribution |
|
|
Certificate Distributions |
|
14:46 - 15:00 |
Lunch |